Connection

Thomas Keane to Cisplatin

This is a "connection" page, showing publications Thomas Keane has written about Cisplatin.
Connection Strength

0.275
  1. Camptothecin analogues/cisplatin: an effective treatment of advanced bladder cancer in a preclinical in vivo model system. J Urol. 1998 Jul; 160(1):252-6.
    View in: PubMed
    Score: 0.143
  2. Dipyridamole-cisplatin potentiation: enhanced in vivo cytotoxicity in xenograft models of human testicular and bladder cancers. J Urol. 1990 Oct; 144(4):1004-9.
    View in: PubMed
    Score: 0.083
  3. Combination versus single agent therapy in effecting complete therapeutic response in human bladder cancer: analysis of cisplatin and/or 5-fluorouracil in an in vivo survival model. Cancer Res. 1994 Jan 15; 54(2):475-81.
    View in: PubMed
    Score: 0.026
  4. The therapeutic impact of dipyridamole: chemopotentiation of the cytotoxic combination 5-fluorouracil/cisplatin in an animal model of human bladder cancer. J Urol. 1991 Nov; 146(5):1418-24.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.